Gut Microbiota Post Roux-en-Y Gastric Bypass Surgery
| Status: | Completed |
|---|---|
| Conditions: | Obesity Weight Loss |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 8/25/2018 |
| Start Date: | January 2016 |
| End Date: | December 2017 |
The Gut Microbiota in Patients Post Roux-en-Y Gastric Bypass Surgery
The purpose of this study is to investigate mechanisms responsible for weight change in
patients who have undergone weight loss surgery. Specifically, we will compare the gut
microbiota, plasma bile acids, plasma gut peptides (GLP-1, GLP-2, and PYY), and plasma LPS in
three groups of subjects: 3-5 years post gastric bypass patients who experienced sub-optimal
weight loss, 3-5 years post gastric bypass patients who had successful weight loss, and a
control group who has not had a weight loss surgery and are of similar age, gender, body mass
index as the gastric bypass groups.
patients who have undergone weight loss surgery. Specifically, we will compare the gut
microbiota, plasma bile acids, plasma gut peptides (GLP-1, GLP-2, and PYY), and plasma LPS in
three groups of subjects: 3-5 years post gastric bypass patients who experienced sub-optimal
weight loss, 3-5 years post gastric bypass patients who had successful weight loss, and a
control group who has not had a weight loss surgery and are of similar age, gender, body mass
index as the gastric bypass groups.
Inclusion Criteria:
- Female
- Age 18-65
- 3-5 years post Roux-en-Y gastric bypass and experienced successful weight loss
following surgery (up to n=10) or
- 3-5 years post Roux-en-Y gastric bypass and did not experience optimal weight loss
following surgery (up to n=10) or
- Nonsurgical control participants who are approximately matched in sex, age, and BMI to
the optimal weight loss group (up to n=10).
Exclusion Criteria:
- Tobacco use in past three months.
- Taking a medication which is known to significantly influence gastrointestinal transit
time or affect the microbiome or other variables significantly (as determined by study
pharmacist/MD).
- History of diabetes mellitus.
- Has taken an oral or IV/IM antibiotic in the past 3 months.
- Has taken probiotic and/or prebiotic agent in the past 3 months
- History of significant intestinal disease or disorder (e.g., Crohn's disease,
ulcerative colitis, irritable bowel syndrome)
- History of gastrointestinal surgery that may impact measures of biological variables,
as determined by the investigator.
- Medical condition expected to impact the biological variables of interest or interfere
with providing a sample, as determined by the investigator.
- Unable to speak/read English.
- Breastfeeding, pregnant, or planning to become pregnant within the duration of the
study.
- Unwilling to use a medically acceptable form of contraception.
- History of bipolar or psychotic spectrum disorder or alcohol or substance treatment in
the past year
We found this trial at
1
site
Click here to add this to my saved trials
